Akriti Singh

Kolkata, WB, India

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications

Synthetic Versus Reference Semaglutide for Weight Management: Reporting Gaps and Clinical Claims.

Synthetic Versus Reference Semaglutide for Weight Management: Reporting Gaps and Clinical Claims.

Journal: Diabetes, obesity & metabolism
Published: July 18, 2026

Betel nut aspiration causing cold abscess-like endobronchial lesion and right lung upper lobe collapse in an elderly patient.

Betel nut aspiration causing cold abscess-like endobronchial lesion and right lung upper lobe collapse in an elderly patient.

Journal: BMJ case reports
Published: July 07, 2026

Short-Term HbA1c Non-Inferiority of Synthetic Semaglutide Should Not Be Conflated With Full Therapeutic Interchangeability.

Short-Term HbA1c Non-Inferiority of Synthetic Semaglutide Should Not Be Conflated With Full Therapeutic Interchangeability.

Journal: Diabetes, obesity & metabolism
Published: June 30, 2026

Periconceptional GLP-1 Receptor Agonist Exposure: Lower Observed Risk or Lower Certainty?

Periconceptional GLP-1 Receptor Agonist Exposure: Lower Observed Risk or Lower Certainty?

Journal: JACC. Advances
Published: June 22, 2026

Inadvertent glucagon-like peptide-1 receptor agonist exposure in pregnancy: reassuring data, unresolved safety (letter to the editor).

Inadvertent glucagon-like peptide-1 receptor agonist exposure in pregnancy: reassuring data, unresolved safety (letter to the editor).

Journal: American journal of obstetrics and gynecology
Published: June 18, 2026

Giant hydronephrosis mimicking subacute intestinal obstruction: A 4-case series.

Giant hydronephrosis mimicking subacute intestinal obstruction: A 4-case series.

Journal: Radiology case reports
Published: November 20, 2025

Revisiting Diabetes Classification: Insights Challenges and Clinical Relevance of the ANDIS Framework in the Indian Context.

Revisiting Diabetes Classification: Insights Challenges and Clinical Relevance of the ANDIS Framework in the Indian Context.

Journal: The Journal of the Association of Physicians of India
Published: June 24, 2025

Have SGLT-2 inhibitors DELIVERed an EMPhatic win in heart failure and chronic kidney disease?

Have SGLT-2 inhibitors DELIVERed an EMPhatic win in heart failure and chronic kidney disease?

Journal: Expert opinion on pharmacotherapy
Published: February 07, 2025

Comparative efficacy and safety of semaglutide 2.4 mg and tirzepatide 5-15 mg in obesity with or without type 2 diabetes: A systematic review of Phase 3 clinical trials.

Comparative efficacy and safety of semaglutide 2.4 mg and tirzepatide 5-15 mg in obesity with or without type 2 diabetes: A systematic review of Phase 3 clinical trials.

Journal: Diabetes & metabolic syndrome
Published: January 27, 2025

Efficacy and safety of oral semaglutide in type 2 diabetes: A systematic review of real-world evidence.

Efficacy and safety of oral semaglutide in type 2 diabetes: A systematic review of real-world evidence.

Journal: Diabetes & metabolic syndrome
Published: March 25, 2024

Diet in Thyroid Disorders: A Survey among Clinicians and a Review of the Current Perspective.

Diet in Thyroid Disorders: A Survey among Clinicians and a Review of the Current Perspective.

Journal: Indian journal of endocrinology and metabolism
Published: February 28, 2024

Non-sugar sweeteners and health outcomes in adults without diabetes: deciphering the WHO recommendations in the Indian context.

Non-sugar sweeteners and health outcomes in adults without diabetes: deciphering the WHO recommendations in the Indian context.

Journal: Diabetes & metabolic syndrome
Published: June 21, 2023
Showing 1-12 of 25

Last Updated: 09/26/2026